Service profile
Outlook Therapeutics Inc.
Biopharmaceutical company developing ophthalmic therapies including ONS-5010, a biosimilar candidate to bevacizumab for wet age-related macular degeneration and other retinal diseases.
About
What Outlook Therapeutics Inc. is
Biopharmaceutical company developing ophthalmic therapies including ONS-5010, a biosimilar candidate to bevacizumab for wet age-related macular degeneration and other retinal diseases.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://outlooktherapeutics.com |
| Status coverage | Public status page |
| Founded | 2010 |
| Headquarters | Iselin, New Jersey, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...
Alternatives
